HIF1A and lung cancer: In lung cancer, miR-23a secreted in tumor-derived exosomes in hypoxia was reported to target the key HIF-1α regulators (propyl hydroxylases PHD1 and PHD2), thereby sustaining the overexpression of HIF-1α and promoting angiogenesis[92].